Medicine & Life Sciences
Filarial Elephantiasis
100%
Mass Drug Administration
75%
Coronavirus
63%
Albendazole
59%
Ivermectin
49%
SARS Virus
40%
Diethylcarbamazine
38%
Microfilariae
34%
Bronchiolitis
25%
Psychological Burnout
25%
Respiratory Syncytial Viruses
24%
Infections
23%
Pandemics
23%
Liberia
21%
Osteotomy
21%
Confidence Intervals
19%
Helminths
19%
Rwanda
19%
Wuchereria bancrofti
19%
Safety
18%
Asthma
18%
Population Characteristics
17%
Mental Health
17%
Hip
17%
Azithromycin
16%
Physicians
16%
Metabolomics
15%
Patient Reported Outcome Measures
15%
Respiratory Sounds
15%
Cholestenones
14%
Electronic Health Records
14%
Hypertension
13%
Acute Kidney Injury
13%
Papua New Guinea
12%
Haiti
12%
Bronchial Thermoplasty
12%
Loiasis
11%
Pharmaceutical Preparations
11%
Clinical Trials
11%
Depression
11%
Antigens
11%
Hookworm Infections
10%
Anxiety
10%
Child
10%
Indonesia
10%
Pituitary Diseases
9%
Randomized Controlled Trials
9%
beta 2-Microglobulin
9%
Medical Genetics
9%
Agriculture & Biology
Bancroftian filariasis
22%
Liberia
21%
albendazole
20%
helminthiasis
17%
ivermectin
16%
drugs
14%
Anopheles quadrimaculatus
10%
meteorology
10%
microfilariae
10%
geology
9%
praziquantel
9%
immunoaffinity chromatography
9%
enterotoxigenic Escherichia coli
9%
land cover
9%
antibody detection
8%
adaptive immunity
8%
Sri Lanka
8%
antigens
7%
interspecific competition
7%
infection
7%
wetlands
6%
Wuchereria bancrofti
6%
Indonesia
6%
confidence interval
6%
Heterandria formosa
6%
fauna
5%
fish
5%
virulence
5%
predation
5%
rivers
5%
immatures
5%
Notonectidae
5%
Gambusia holbrooki
5%
agriculture
5%
Social Sciences
Drug Administration
33%
Haiti
12%
adverse events
12%
Papua-New Guinea
12%
drug
9%
hypertension
8%
Cameroon
8%
community research
8%
Rwanda
7%
Pole
7%
cardiovascular disease
7%
educational opportunity
7%
trainee
6%
resident
6%
emergency care
5%
health service
5%
regression
5%
WHO
5%
physician
5%